Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR8 | Q9NR97 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | POLB | P06746 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | ALPG | P10696 | 2/20 | 0.39 |
| ▸ | PLAA | Q9Y263 | 1/20 | 0.39 |
| ▸ | ALPL | P05186 | 1/20 | 0.38 |
| ▸ | KCNH2 | Q12809 | 4/20 | 0.38 |
| ▸ | CA12 | O43570 | 2/20 | 0.36 |
| ▸ | CA1 | P00915 | 2/20 | 0.36 |
| ▸ | CA2 | P00918 | 2/20 | 0.36 |
| ▸ | CA9 | Q16790 | 2/20 | 0.36 |
| ▸ | ARG1 | P05089 | 1/20 | 0.36 |
| ▸ | CA3 | P07451 | 1/20 | 0.36 |
| ▸ | CA4 | P22748 | 1/20 | 0.36 |
| ▸ | CA6 | P23280 | 1/20 | 0.36 |
| ▸ | CA5A | P35218 | 1/20 | 0.36 |
| ▸ | CA7 | P43166 | 1/20 | 0.36 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.36 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Hydrochloric Acid SCHEMBL11091402 | 0.98 | TLR8 (0.53) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL27627065 | 0.95 | TLR8 (0.54) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL2792249 | 0.89 | TLR8 (0.46) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL22356840 | 0.86 | TLR8 (0.49) | TLR8ALDH1A1POLBKMT2AKCNH2 | |
| SCHEMBL329466 | 0.85 | ALDH1A1 (0.63) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL27627062 | 0.84 | TLR8 (0.51) | TLR8ALDH1A1POLBKMT2AKCNH2 | |
| Iodide SCHEMBL4267902 | 0.83 | ALDH1A1 (0.61) | TLR8ALDH1A1POLBKMT2AALPG | |
| Hydrochloric Acid SCHEMBL28286020 | 0.83 | ALDH1A1 (0.61) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL4227901 | 0.83 | TLR8 (0.68) | TLR8ALDH1A1POLBKMT2AALPG | |
| SCHEMBL10530747 | 0.82 | TLR8 (0.53) | TLR8ALDH1A1POLBKMT2AKCNH2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 107 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11471821-B2 | Process for biogas upgradation | INDIAN OIL CORPORATION LIMITED (IN) | 2022-10-18 | — | — | US | claimed |
| CN-109476803-B | Amine compositions useful for making polyurethane foams | 赢创运营有限公司 | 2022-04-12 | — | — | CN | claimed |
| EP-1971600-B1 | ISOXAZOLE DERIVATIVES AND USE THEREOF | SK BIOPHARMACEUTICALS CO LTD (KR) | 2013-08-21 | — | — | EP | claimed |
| US-7479527-B2 | Polyepoxide and reaction product of aminoalkylimidazole, polyamine, urea and diepoxide as curing component | FUJI KASEI KOGYO CO., LTD. (JP) | 2009-01-20 | — | — | US | claimed |
| EP-4747320-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | Henkel AG & Co. KGaA (DE) | 2026-05-27 | — | — | EP | disclosed |
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | HENKEL AG & CO KGAA (DE) | 2026-05-21 | — | — | US | disclosed |
| US-12570797-B2 | Acid functional compound | BYK-CHEMIE GMBH (DE) | 2026-03-10 | — | — | US | disclosed |
| EP-4526365-A1 | ACRYLATE-EPOXY RESIN COMPOSITIONS | Lyondellbasell Composites LLC (US) | 2025-03-26 | — | — | EP | disclosed |
| WO-2025015542-A1 | THERMAL-AND UV-CURABLE (METH) ACRYLATE COMPOSITION | HENKEL AG & CO. KGAA (DE) | 2025-01-23 | — | — | WO | disclosed |
| EP-3665209-B1 | AN AMINE FUNCTIONAL COMPOUND | BYK CHEMIE GMBH (DE) | 2024-11-20 | — | — | EP | disclosed |
| US-20240327582-A1 | RAPID CURING EPOXY-RESIN COMPOSITION FOR FIBER-MATRIX SEMIFINISHED PRODUCTS | POLYNT COMPOSITES NORWAY AS (NO) | 2024-10-03 | — | — | US | disclosed |
| US-20230416522-A1 | ACRYLATE-EPOXY RESIN COMPOSITIONS | LYONDELLBASELL COMPOSITES LLC (US) | 2023-12-28 | — | — | US | disclosed |
| US-4576957-A | HYPOTENSIVE | AMERICAN CYANAMID COMPANY (US) | 1986-03-18 | — | — | US | disclosed |
| US-4568687-A | THROMBOXANE SYNTHETASE TNZYME INHIBITORS; HYPOTENSIVE AGENTS, CARDIOTONIC AGENTS | AMERICAN CYANAMID COMPANY (US) | 1986-02-04 | — | — | US | disclosed |
| EP-0091641-B1 | N-SUBSTITUTED IMIDAZOLE DERIVATIVES, THEIR PREPARATION, PHARMACEUTICAL COMPOSITIONS CONTAINING THEM AND THEIR USE | BASF Aktiengesellschaft (DE) | 1986-01-02 | — | — | EP | disclosed |
| US-4555519-A | Thromboxane synthetase enzyme inhibiting N-[(1H-imidazol-1-yl) and (1H-1,2,4-triazol-1-yl)alkyl]pyridinecarboxamides | AMERICAN CYANAMID COMPANY (US) | 1985-11-26 | — | — | US | disclosed |
| US-4514413-A | ANTACIDS | BASF AKTIENGESELLSCHAFT (DE) | 1985-04-30 | — | — | US | disclosed |
| EP-0117462-A2 | N-(2-4-(1H-imidazol-1-yl)alkyl)arylamides | AMERICAN CYANAMID COMPANY (US) | 1984-09-05 | — | — | EP | disclosed |
| EP-0091641-A1 | N-substituted imidazole derivatives, their preparation, pharmaceutical compositions containing them and their use | BASF Aktiengesellschaft (DE) | 1983-10-19 | — | — | EP | disclosed |
| US-3949076-A | GASTRIC ACID SECRETION INHIBITION | SMITHKLINE CORPORATION (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260139157-A1 | THERMAL-AND-UV-CURABLE (METH)ACRYLATE COMPOSITION | MAT1A, MAT2B, MAT2A | TLR8 2733/4885ALDH1A1 139/4885POLB 1381/4885 |
| US-12570797-B2 | Acid functional compound | ELOVL1, ELOVL6, ELOVL5 | TLR8 2149/4885ALDH1A1 306/4885POLB 4423/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.